Investigative Ophthalmology & Visual Science Cover Image for Volume 63, Issue 7
June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Patient Perspective of Telehealth for Retinal Disease during the COVID-19 Pandemic
Author Affiliations & Notes
  • Neha Chittaluru
    University of Central Florida, Orlando, Florida, United States
  • Davis Bhagat
    University of Illinois at Chicago, Chicago, Illinois, United States
  • Prem Patel
    The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Veeral Sheth
    University of Illinois at Chicago, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Neha Chittaluru None; Davis Bhagat None; Prem Patel None; Veeral Sheth Genentech, Novartis, Alimera, EyePoint, IvericBio, Graybug, Apellis, Allergan, Opthea, Oxurion, Recens Medical, Roche, Regenxbio, Ionis, Regeneron, Santen, SamChungDang, Gyroscope, Chengdu Kanghong, SalutarisMD, NGM Biopharmaceuticals, Alimera Sciences, Outlook, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1390 – A0086. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Neha Chittaluru, Davis Bhagat, Prem Patel, Veeral Sheth; Patient Perspective of Telehealth for Retinal Disease during the COVID-19 Pandemic. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1390 – A0086.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Amidst the COVID-19 pandemic, telemedicine has emerged as a safe and cost-effective alternative to traditional, in-person ophthalmology clinic visits. To better understand the implications of this technology on the patient-physician relationship, this study assessed patient perspectives about telemedicine to identify areas for improvement.

Methods : A cross-sectional survey was distributed to patients at University Retina during July 2021. Responses regarding telehealth’s ability to ease anxiety of contracting COVID-19, efficiency, patient education, quality of examination, and convenience were collected on a 5-point Likert scale. A positive attitude was defined as ≥ 4 average Likert rating for all questions. Frequencies of positive attitudes were compared across demographic factors by the Pearson chi-square test. Multivariate analysis was used to evaluate factors influencing patient preference for telehealth over traditional visits.

Results : Of 103 respondents, most were female (53.8%), aged 65-74 (34.6%), and high school educated (46.2%). 38% of patients did not know their diagnosis and 62.1% had no prior history of telehealth usage. Overall, patients had a neutral attitude towards telehealth (mean Likert rating (SD) = 3.11/5 ± 0.82). Nearly one-third (31%) preferred telehealth over face-to-face visits. Questions regarding “patient education” had the greatest proportion of positive attitude, whereas “efficiency” had a largely negative attitude (both 63.1%). “Convenience” of telehealth yielded the highest number of responses in strong agreement or disagreement (38.9%). Patients with no history of telehealth usage more frequently reported negative attitudes compared to those with prior experience (87.5% vs. 71.8%, p = 0.046). Patients tended to respond more positively as education level increased, but this trend was not statistically significant (p = 0.18). On multivariate analysis, patients younger than 75 were more likely to prefer telehealth over in-person visits compared to patients 75 or older (odds ratio [OR] = 2.25, p = .007). Patient gender, knowledge of diagnosis, and history of past telehealth usage did not predict preference for telemedicine.

Conclusions : Patients responded with a net neutral outlook on telehealth, indicating room for improvement. Efforts should focus on addressing technological inefficiencies and age-related barriers to patient satisfaction.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×